Abbott Labs Stock Offers Favorable Entry Point Hosted by Laycee KluinOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.8746 of 5 stars$133.61-0.2%1.77%17.46 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored15 REITs That Wall Street Analysts Love in Today's MarketThere are more than 200 publicly-traded real-estate investment trusts (REITs) that you can buy through your br...MarketBeatBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredHow to Invest In Growth StocksThe stock market has been growing since the New York Stock Exchange opened its doors in 1817. Sometimes, a sto...MarketBeatA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | Sponsored7 Technology Stocks That Analysts Love The MostThere are more than 1,100 technology companies traded on public markets in the United States. Many of these co...MarketBeat Listen to MarketBeat Other Platforms Recent Videos Featured Articles and OffersWhy Super Micro Computer's Upside Could Trigger a Short SqueezeJune 3, 2025View Why Super Micro Computer's Upside Could Trigger a Short SqueezeA better hedge than gold?From Porter & Company(Ad)View A better hedge than gold?3 Top-Rated Energy Companies Staging Strong RecoveriesJune 2, 2025View 3 Top-Rated Energy Companies Staging Strong RecoveriesAmong the Market’s Most Shorted: 2 Firms With +40% Short InterestJune 3, 2025View Among the Market’s Most Shorted: 2 Firms With +40% Short Interest3 Companies to Buy on This Early Cycle RecoveryJune 3, 2025View 3 Companies to Buy on This Early Cycle RecoveryTrump’s treachery From Porter & Company(Ad)View Trump’s treachery Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.8746 of 5 stars$133.61-0.2%1.77%17.46 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored15 REITs That Wall Street Analysts Love in Today's MarketThere are more than 200 publicly-traded real-estate investment trusts (REITs) that you can buy through your br...MarketBeatBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredHow to Invest In Growth StocksThe stock market has been growing since the New York Stock Exchange opened its doors in 1817. Sometimes, a sto...MarketBeatA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | Sponsored7 Technology Stocks That Analysts Love The MostThere are more than 1,100 technology companies traded on public markets in the United States. Many of these co...MarketBeat
